| 1 |
34889524 | Functional characterization and potential therapeutic avenues for variants in the NTRK2 gene causing developmental and epileptic encephalopathies. | 2022 Jan |
1 |
| 2 |
35222122 | Influence of Prenatal Drug Exposure, Maternal Inflammation, and Parental Aging on the Development of Autism Spectrum Disorder. | 2022 |
1 |
| 3 |
32725456 | Valproic Acid: A Potential Therapeutic for Spinal Cord Injury. | 2021 Oct |
2 |
| 4 |
34685502 | Acute Valproate Exposure Induces Mitochondrial Biogenesis and Autophagy with FOXO3a Modulation in SH-SY5Y Cells. | 2021 Sep 23 |
1 |
| 5 |
31911180 | Enhanced signaling via ERBB3/PI3K plays a compensatory survival role in pancreatic tumor cells exposed to [neratinib + valproate]. | 2020 Apr |
1 |
| 6 |
33356493 | Valproic Acid Enhanced Apoptosis by Promoting Autophagy Via Akt/mTOR Signaling in Glioma. | 2020 Jan-Dec |
4 |
| 7 |
31010254 | Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro. | 2019 Apr 19 |
2 |
| 8 |
31551670 | Valproic Acid Enhances Reprogramming Efficiency and Neuronal Differentiation on Small Molecules Staged-Induction Neural Stem Cells: Suggested Role of mTOR Signaling. | 2019 |
2 |
| 9 |
28153093 | Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency. | 2017 Feb 1 |
2 |
| 10 |
28494938 | PI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications. | 2017 May 9 |
1 |
| 11 |
29299126 | HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells. | 2017 Dec 15 |
1 |
| 12 |
27588130 | Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells. | 2016 Sep |
1 |
| 13 |
25627160 | Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. | 2015 Jan 20 |
1 |
| 14 |
26735433 | Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation. | 2015 |
2 |
| 15 |
24361750 | Valproic acid enhances Oct4 promoter activity through PI3K/Akt/mTOR pathway activated nuclear receptors. | 2014 Mar 5 |
1 |
| 16 |
24779401 | Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells. | 2014 Jul |
1 |
| 17 |
23292124 | Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma. | 2013 Feb |
1 |
| 18 |
23866964 | Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma. | 2013 Jul 18 |
1 |
| 19 |
21192952 | Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001. | 2011 Feb 28 |
1 |
| 20 |
21360059 | Valproic acid modulates superoxide dismutase, uric acid-independent FRAP and zinc in blood of adult epileptic patients. | 2011 Dec |
1 |
| 21 |
16304046 | FLT3-ITD-, but not BCR/ABL-transformed cells require concurrent Akt/mTor blockage to undergo apoptosis after histone deacetylase inhibitor treatment. | 2006 Mar 1 |
1 |